Press Releases Archives - Page 90 of 103 - Lupin

BSE 2326.70 NSE 2327.70

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2326.70 NSE 2327.70

Lupin licenses us rights for proprietary bioadhesive technology for rifaximin to salix pharmaceuticals

October 5, 2009

Lupin Expands Branded Play Announces Acquisition of US Rights to ANTARA

September 25, 2009

Lupin ties up with leading Institutes for PhD Program

September 18, 2009

Lupin Net Profit up by 25 % in Q1, FY 2009-10 Outpacing and Outperforming Markets globally

Lupin Expands Branded Play Announces Acquisition of Worldwide Rights for its first NDA – AllerNaze™

Lupin Q4 & FY 2008-09 Results – Consistent Performance & Solid Growth

Lupin Announces Litigation Settlement with Wyeth for Venlafaxine Extended Release Capsules

Alliance to commercialize generic equivalent of FOSRENOL® Tablets

Lupin acquires majority stake in Multicare Pharmaceuticals Philippines, Inc.

Lupin Q3 FY 08-09 – Strong Growth & Consistent Performance

January 29, 2009

1 2 … 89 90 91 … 102 103

Search

Hit enter to search or ESC to close